CTHA、CTAP在肝癌介入治疗后复查中的作用和意义  

The Application and Significance of CTHA and CTAP in Reexamination of Liver Cancer after Interventional Therapy

作　　者：杨海珺[1] 韩铭钧[1] 任克[1] 

机构地区：[1]中国医科大学第一附属医院放射科,沈阳110001

出　　处：《临床放射学杂志》2000年第2期107-109,共3页Journal of Clinical Radiology

基　　金：辽宁省自然科学基金!(No:981 0 50 0 1 0 2 );国家"九.五"攻关课题基金! (No :9690 70 30 1 )

摘　　要：目的　研究CTHA、CTAP在肝癌介入治疗复查中的应用价值和意义。材料与方法　 14例原发性肝癌TAE术后患者进行CTHA、CTAP检查。结果　CTHA、CTAP发现已栓塞灶周边复发 2 1个 ( 91.3 % ) ,新病灶 3 7个 ( 92 .5 % )。CTHA、CTAP清晰显示了肝硬化结节的形态及血供变化。结论　CTHA、CTAP是肝癌介入治疗复查中最敏感和特异的方法 ,对于评价疗效及早期发现病灶都有重要作用。Objective To investigate the application and significance of CTHA and CTAP in reexamination of liver cancer after interventional therapy.Materials and Methods CTHA and CTPA were performed in 14 patients with primary hepatic cancer after receiving TAE.Results CTHA and CTPA discovered 21 (91.3%) recurrent lesions in the peripheral region of embolized tumors, and 37 (92.5%) new lesions. The cirrhotic nodules and flow changes were well demonstrated. Conclusion CTHA and CTPA are the most sensitive and specific method for the reexamination of liver cancer after interventional therapy, and play an important role in evaluating therapeutic effect and detecting early lesions.

关 键 词：肝肿瘤 复查 肝癌 介入疗法 CTHA CTAP 

分 类 号：R735.7[医药卫生—肿瘤]